Predictive Oncology

Dr Pamela Bush Predictive Oncology
Business

Business

  (Eagan, MN) — Feb. 03, 2023 WIRE) — Predictive Oncology Inc. (NASDAQ: POAI) is pleased to announce the appointment of Pamela Bush, Ph.D., MBA, as Chief Business Officer. Dr. Bush will lead all business development, partnering and growth strategies for Predictive Oncology. As a key member of the executive team, Dr. Bush will spearhead the company’s strategic, operational and financial planning initiatives for both existing customers and emerging new

Marc Malandro Ph.D.
People

People

  (Eagan, MN) — Dec. 13, 2022  — Predictive Oncology Inc. today announced the appointment of Marc Malandro, Ph.D., to the company’s Scientific Advisory Board where he will serve alongside other key thought leaders in their respective fields to guide the company’s scientific initiatives and growth strategy. A highly regarded scientific leader with significant experience in business, law and philanthropy, Dr. Malandro currently serves as the Vice President of Operations

Matthew J. Hawryluk Ph.D Predictive Oncology
Featured

Featured, People

  (Eagan, MN)  — Dec. 05, 2022  — Predictive Oncology Inc. (NASDAQ: POAI) is pleased to announce the appointment of Matthew J. Hawryluk, Ph.D. to its Board of Directors to help support the company’s strategic initiatives and commercialization efforts. Dr. Hawryluk currently serves as Executive Vice President and Chief Business Officer of Gritstone bio, Inc Recognized by Pharmaceutical Executive magazine as a leading business executive in the pharma and biotech

David S. Smith Predictive Oncology
People

People

  EAGAN, Minn., Oct. 25, 2022 (GLOBE NEWSWIRE) — Predictive Oncology is pleased to announce the appointment of David S. Smith, JD, to the company’s Board of Directors. Mr. Smith is a life sciences and corporate attorney, veteran biotech industry executive and leading authority on the legal issues surrounding the therapeutic use of human tissue and cells. He has extensive transactional experience, venture financings and regulatory matters for life sciences

Predictive Oncology Mel Engle
People

People

  (Eagan, MN) —  Sept. 16, 2022  — Predictive Oncology (NASDAQ: POAI) announced that J. Melville (“Mel”) Engle will retire as Chief Executive Officer and as Chairman and a member of the company’s Board of Directors. To ensure a smooth transition of his responsibilities, Mr. Engle will continue to serve in his role through October 31, 2022. Pursuant to policies regarding leadership succession, the governance committee of POAI’s Board of